Patents by Inventor Laura Jean Weston

Laura Jean Weston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BROMOCRIPTINE FORMULATIONS
    Publication number: 20240131026
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: April 26, 2023
    Publication date: April 25, 2024
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 11666567
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: June 6, 2023
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • BROMOCRIPTINE FORMULATIONS
    Publication number: 20210228576
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: April 9, 2021
    Publication date: July 29, 2021
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 11000522
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: May 19, 2020
    Date of Patent: May 11, 2021
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20200276193
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: May 19, 2020
    Publication date: September 3, 2020
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 10688094
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: April 24, 2019
    Date of Patent: June 23, 2020
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • PHARMACEUTICAL FORMULATIONS AND THEIR USE
    Publication number: 20200179319
    Abstract: Disclosed herein are pharmaceutical compositions, comprising a therapeutically effective amount of 4-((1-carboxy-2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)thio)ethyl)amino)-4-oxobutanoic acid, or a pharmaceutically acceptable salt thereof, and at least one protective agent, and uses thereof.
    Type: Application
    Filed: August 4, 2017
    Publication date: June 11, 2020
    Applicant: Signum Biosciences, Inc.
    Inventors: Thomas John Willi, John Frederick Lang, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20190343833
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: April 24, 2019
    Publication date: November 14, 2019
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 10307421
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: May 16, 2018
    Date of Patent: June 4, 2019
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20180263978
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: May 16, 2018
    Publication date: September 20, 2018
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9993474
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: June 12, 2018
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20170340632
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: June 8, 2017
    Publication date: November 30, 2017
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9700555
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: July 11, 2017
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20170020871
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: October 6, 2016
    Publication date: January 26, 2017
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9522117
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: October 22, 2015
    Date of Patent: December 20, 2016
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20160038424
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: October 22, 2015
    Publication date: February 11, 2016
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 9192576
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycerine control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: November 22, 2013
    Date of Patent: November 24, 2015
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • BROMOCRIPTINE FORMULATIONS
    Publication number: 20140187560
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycerine control in the treatment of type 2 diabetes.
    Type: Application
    Filed: November 22, 2013
    Publication date: July 3, 2014
    Applicant: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Stearns, Laura Jean Weston
  • Bromocriptine formulations
    Patent number: 8613947
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: December 24, 2013
    Assignee: VeroScience LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Steams, Laura Jean Weston
  • Bromocriptine Formulations
    Publication number: 20130287848
    Abstract: The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
    Type: Application
    Filed: February 21, 2013
    Publication date: October 31, 2013
    Applicant: VEROSCIENCE LLC
    Inventors: Anthony H. Cincotta, Craig Michael Bowe, Paul Clark Steams, Laura Jean Weston